Methylphenidate and the Cytochrome P450 System

Ickowicz A. Buproprion-methylphenidate combination and grand-mal seizures. Can J Psychiatry 2002;47:790–1.

Biederman J. Attention-deficit-hyperactivity disorder: A life-span perspective. J Clin Psychiatry 1998;59:137–49.

Rosenbaum JF Fava M Nierenberg A Sachs GS . Treatment-resistant mood disorder. In: Gabbard GO , editor. Treatment of psychiatric disorders. 3rd ed. Washington (DC): American Psychiatric Press; 2001. p 1307–88.

Potter WZ Manji HK Rudorfer MV . Tricyclics and tetracyclics. In: Schatzberg AF Nemeroff CB , editors. Textbook of psychopharmacology. Washington (DC): American Psychiatric Press; 1995. p 141–60.

Dulcan MK Bregman JD Weller EB Weller RA . Treatment of childhood and adolescent disorders. In: Schatzberg AF Nemeroff CB , editors. Textbook of psychopharmacology. Washington (DC): American Psychiatric Press; 1995. p 669–706.

Stoudemire A Moran MG Fogen BS . Psychopharmacology in the medically ill patient. In: Schatzberg AF Nemeroff CB , editors. Textbook of psychopharmacology. Washington (DC): American Psychiatric Press; 1995. p 783–801.

Cozza KL Armstrong SC . The cytochrome P450 system: Drug interaction principles for medical practice. Washington (DC): American Psychiatric Publishing; 2001.

Indiana University Department of Medicine. Cytochrome P450 Drug Interaction Table 2002. www.Drug-Interactions.Com.

Murray L Kelly G , editors. Physicians' desk reference. Montvale (NJ): Medical Economics Co; 2001.

Preskorn SH Burke MJ Fast GA . Therapeutic drug monitoring principles and practice. Psychiatr Clin North Am 1993;16:611–45.